Table 4.
Effects of the NEURO TRONIC SCKAFO compared with those of the E-MAG active SCKAFO on perceived effectiveness with standing and walking ability.
| T0 E-MAG active | T2 NEURO TRONIC | Delta T2–T0 | ||
| Median (IQR) | Median (IQR) | Median (IQR) | p | |
| Walking distance | 4.0 (3.0–5.0) | 5.0 (4.0–6.0) | 0.0 (0.0–2.0) | 0.066 |
| Walking speed | 3.0 (3.0–4.5) | 4.0 (2.5–5.0) | 0.0 (−1.0 to 1.5) | 0.518 |
| Walking stability | 6.0 (4.5–7.0) | 7.0 (5.0–7.0) | 0.0 (−0.5 to 1.5) | 0.496 |
| Standing stability | 6.0 (5.0–7.0) | 7.0 (5.0–7.0) | 0.0 (−0.5 to 1.0) | 0.783 |
| No. of falls | 5.5 (5.0–6.5) | 6.0 (6.0–7.0) | 0.0 (−0.5 to 1.5) | 0.395 |
| Walking flat surfaces | 6.0 (5.5–7.0) | 6.0 (6.0–7.0) | 0.0 (−0.5 to 1.0) | 0.480 |
| Walking irregular surfaces | 4.0 (3.0–6.0) | 6.0 (3.5–6.0) | 1.0 (−0.5 to 2.0) | 0.196 |
| Walking a slope up | 4.0 (2.5–5.0) | 5.0 (3.0–6.0) | 1.0 (−0.5 to 2.0) | 0.160 |
| Walking a slope down | 3.0 (1.5–5.0) | 4.0 (2.5–5.5) | 0.0 (−0.5 to 1.5) | 0.395 |
| Taking steps up and down | 5.0 (4.0–6.0) | 6.0 (4.5–7.5) | 0.5 (−0.3 to 1.0) | 0.135 |
| Concentrating on walking | 4.0 (2.5–5.0) | 3.0 (3.0–5.5) | 0.0 (−1.0 to 1.5) | 0.891 |
| Pain in orthosis leg | 6.0 (5.0–7.0) | 6.0 (4.5–7.0) | 0.0 (−0.5 to 0.0) | 0.564 |
| Pain in nonorthosis leg | 6.0 (2.5–7.0) | 6.0 (4.0–7.0) | 0.0 (0.0–1.5) | 0.129 |
| Back pain | 5.0 (3.0–7.0) | 6.0 (4.5–7.0) | 0.0 (1.0–2.5) | 0.491 |
| Walking effort | 3.0 (2.0–5.0) | 4.0 (3.0–6.0) | 1.0 (0.5–1.5) | 0.014a |
| Standing effort | 5.0 (3.0–6.5) | 4.0 (3.5–6.5) | 0.0 (−0.5 to 1.0) | 0.891 |
| Overall effectivenessb | 4.8 (0.6) | 5.2 (0.8) | 0.5 (0.6) | 0.060 |
Abbreviation: IQR, interquartile range.
Data are expressed as median (IQR).
Significant at p < 0.05.
Reported as mean (SD). Scores range from 1 to 7 with 7 as most positive score.
